Spring 2019

CERES announces growth financing for Emphysys, a powerhouse product development partner who is changing the future of R&D and new product development.  With specialties in medical devices, semiconductor equipment and industrial machinery, the company is comprised of a diverse group of professionals with extensive backgrounds in fundamental physics and complex engineering systems.

Today’s transformative age is blurring lines between economic sectors, while creating new and unique opportunities.  With this collision of industries, leaders in traditionally defined sectors are seizing opportunities to create new value for their customers and reshape their businesses.

Significant changes to Committee for Foreign Investment in US (CFIUS) review process expand its jurisdiction to new types of transactions and change the timeline and procedures for seeking approval for a transaction from CFIUS.

Buyers address the challenges of slower growth, an abundance of investment capital, advances in digital technologies and government intervention with M & A.  In addition to consolidation and scaling manufacturing operations in Asia, buyers are acquiring companies employing photonics technologies to open new markets, enhance capabilities and implement new business models.

$29B of $822B private placements worldwide goes to work commercializing and growing businesses with core photonics technology.  Communications, LED's, and solar attract the most investment.  Autonomous vehicles, 3D sensing, point-of-care medical diagnostics and AI powered imaging see the most activity.  With exception of smart architectural glass, investment in pure-play photonics lags.